| Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma CA Cox, IM Boudewijn, SJ Vroegop, S Schokker, AJ Lexmond, HW Frijlink, ... Respiratory Medicine 130, 35-42, 2017 | 16 | 2017 |
| Predictors of clinical response to extrafine and non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma F Gafar, IM Boudewijn, CA Cox, JM Vonk, S Schokker, AJ Lexmond, ... Respiratory Research 19, 1-5, 2018 | 9 | 2018 |
| Bronchial provocation testing can be improved by using dry powder adenosine instead of nebulized adenosine monophosphate AJ Lexmond, IM Boudewijn, P Hagedoorn, S Schokker, CA Cox, JM Vonk, ... American Journal of Respiratory and Critical Care Medicine 197 (3), 391-394, 2018 | 6 | 2018 |
| Nasal gene expression changes with inhaled corticosteroid treatment in asthma IM Boudewijn, A Lan, A Faiz, CA Cox, S Brouwer, S Schokker, ... Allergy 75 (1), 191-194, 2020 | 5 | 2020 |
| Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma CA Cox, IM Boudewijn, SJ Vroegop, S Schokker, AJ Lexmond, HW Frijlink, ... BMC Pulmonary Medicine 19, 1-9, 2019 | 4 | 2019 |
| Predicted values for the forced expiratory flow adjusted for forced vital capacity, a descriptive study CA Cox, JM Vonk, HAM Kerstjens, M van den Berge, NHT Ten Hacken ERJ Open Research 6 (4), 2020 | 3 | 2020 |
| Factors associated with hyperresponsiveness to adenosine 5’‐monophosphate in healthy subjects CA Cox, JM Vonk, HAM Kerstjens, M Van den Berge Allergy 74 (11), 2268, 2019 | 3 | 2019 |
| The role of the small airways in (ex-) smokers with or without asthma CA Cox | | 2023 |
| Healthy Subjects with AMP Hyperresponsiveness: The Importance of Smoking CA Cox, JM Vonk, HAM Kerstjens, M van den Berge C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS, A4717 …, 2019 | | 2019 |
| be improved by using dry powder adenosine instead of nebulized adenosine monophosphate AJ Lexmond, IM Boudewijn, P Hagedoorn, S Schokker, CA Cox, JM Vonk, ... Clinical and molecular phenotyping of asthma and COPD 197, 83, 2019 | | 2019 |
| Unraveling adenosine and AMP induced dyspnea sensation in asthma CA Cox, IM Boudewijn, SJ Vroegop, S Schokker, AJ Lexmond, HW Frijlink, ... European Respiratory Journal 52 (suppl 62), 2018 | | 2018 |
| Extrafine compared to non-extrafine particle ICS in smokers and ex-smokers with asthma CA Cox, IM Boudewijn, SJ Vroegop, S Schokker, AJ Lexmond, EW Frijlink, ... European Respiratory Journal 50 (suppl 61), PA521, 2017 | | 2017 |
| An improved bronchial provocation test with dry powder adenosine instead of nebulised adenosine monophosphate (AMP) AJ Lexmond, I Boudewijn, P Hagedoorn, S Schokker, C Cox, J Vonk, ... European Respiratory Journal 50 (suppl 61), 2017 | | 2017 |
| Bronchial Provocation Testing Can Be Improved by Using Dry Powder Adenosine Instead of Nebulized Adenosine Monophosphate. AJ Lexmond, IM Boudewijn, P Hagedoorn, S Schokker, CA Cox, JM Vonk, ... | | 2017 |
| CO diffusion: A graph tells more than a single point C Cox, W van Beurden, F de Jongh European Respiratory Journal 44 (Suppl 58), 2014 | | 2014 |
| Definitions of selection criteria CA Cox, JM Vonk, HAM Kerstjens, M van den Berge, NHT ten Hacken | | |
